Zobrazeno 1 - 10
of 76
pro vyhledávání: '"VINCENZO DE FALCO"'
Autor:
Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, Gabriella Suarato, Rossella Napolitano, Alfonso Esposito, Francesco Caraglia, Maria Cristina Giugliano, Eleonora Cioli, Vincenzo Famiglietti, Roberto Bianco, Giuseppe Argenziano, Andrea Ronchi, Davide Ciardiello, Valerio Nardone, Emma D’Ippolito, Sara Del Tufo, Fortunato Ciardiello, Teresa Troiani
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Cemiplimab has demonstrated relevant clinical activity in cutaneous squamous cell carcinoma (cSCC) but mechanisms of primary and acquired resistance to immunotherapy are still unknown. We collected clinical data from locally advanced and/or metastati
Externí odkaz:
https://doaj.org/article/c5266e85e64141d58178111000be05fd
Autor:
Vitale Del Vecchio, Ayesha Rehman, Sameer Kumar Panda, Martina Torsiello, Martina Marigliano, Maria Maddalena Nicoletti, Giuseppe Andrea Ferraro, Vincenzo De Falco, Rosamaria Lappano, Eva Lieto, Francesca Pagliuca, Carlo Caputo, Marcella La Noce, Gianpaolo Papaccio, Virginia Tirino, Nirmal Robinson, Vincenzo Desiderio, Federica Papaccio
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-17 (2024)
Abstract Background Breast cancer (BC) is a complex disease, showing heterogeneity in the genetic background, molecular subtype, and treatment algorithm. Historically, treatment strategies have been directed towards cancer cells, but these are not th
Externí odkaz:
https://doaj.org/article/3a0b4cf17b544ce2a70d5d0c9f16b631
Autor:
Valentina Belli, Stefania Napolitano, Vincenzo De Falco, Gabriella Suarato, Alessandra Perrone, Luigi Pio Guerrera, Giulia Martini, Carminia Maria Della Corte, Erika Martinelli, Floriana Morgillo, Mimmo Turano, Maria Furia, Giuseppe Argenziano, Davide Ciardiello, Fortunato Ciardiello, Teresa Troiani
Publikováno v:
Translational Medicine Communications, Vol 8, Iss 1, Pp 1-11 (2023)
Abstract The BRAF and MEK inhibitors combined strategies have dramatically changed the outcome of BRAF-mutated metastatic melanoma patients. However, despite the initial promising results, the onset of primary or acquired resistance occurs in nearly
Externí odkaz:
https://doaj.org/article/321e7a32845d4f3e8d09565a7fe6c730
Autor:
Vincenzo De Falco, Pasquale Vitale, Christian Brancati, Giuseppe Cicero, Annunziata Auriemma, Raffaele Addeo
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionHead and neck carcinoma (HNC) is a disease with a poor prognosis despite currently available treatments. The management of patients with this tumor is often complicated by several comorbidities. Among these, diabetes is the second most fr
Externí odkaz:
https://doaj.org/article/3f93f983c9134327afa4d056fe74b737
Autor:
Pietro Paolo Vitiello, Giulia Martini, Luigi Mele, Emilio Francesco Giunta, Vincenzo De Falco, Davide Ciardiello, Valentina Belli, Claudia Cardone, Nunzia Matrone, Luca Poliero, Virginia Tirino, Stefania Napolitano, Carminia Della Corte, Francesco Selvaggi, Gianpaolo Papaccio, Teresa Troiani, Floriana Morgillo, Vincenzo Desiderio, Fortunato Ciardiello, Erika Martinelli
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-15 (2021)
Abstract Background Despite the advancements in new therapies for colorectal cancer (CRC), chemotherapy still constitutes the mainstay of the medical treatment. For this reason, new strategies to increase the efficacy of chemotherapy are desirable. P
Externí odkaz:
https://doaj.org/article/ee6656f7232f43be80a2f6cd65a8083d
Autor:
Vincenza Caputo, Vincenzo De Falco, Anna Ventriglia, Vincenzo Famiglietti, Erika Martinelli, Floriana Morgillo, Giulia Martini, Carminia Maria Della Corte, Davide Ciardiello, Luca Poliero, Ferdinando De Vita, Michele Orditura, Morena Fasano, Renato Franco, Michele Caraglia, Arianna Avitabile, Roberto Scalamogna, Beatrice Marchi, Fortunato Ciardiello, Teresa Troiani, Stefania Napolitano
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Recently, new evidence of the next-generation sequencing (NGS) liquid biopsy utility in clinical practice has been developed. This assay is emerging as a new promising tool to use as a noninvasive biomarker for cancer mutation profiling.
Externí odkaz:
https://doaj.org/article/52c407b9e9474e63b0fa411f5e4ce61b
Autor:
Raimondo Di Liello, Flora Cimmino, Soraya Simón, Emilio Francesco Giunta, Vincenzo De Falco, Paloma Martín-Martorell
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 1, Iss 3, Pp 183-199 (2020)
Immunotherapy has shifted the therapeutic landscape in thoracic cancers. However, assessment of biomarkers for patient selection and disease monitoring remain challenging, especially considering the lack of tissue sample availability for clinical and
Externí odkaz:
https://doaj.org/article/448528a69946453a8935384a61ab0cfe
Publikováno v:
Dermatology Practical & Conceptual, Vol 11, Iss S1 (2021)
Melanoma is a form of skin cancer that is frequently diagnosed at early stages. In most cases, surgical resection is curative. In case of thicker melanomas (> pT1b) without clinical or instrumental evidence of metastasis, a sentinel lymph node biopsy
Externí odkaz:
https://doaj.org/article/c545f0a9288e4d2bbb4e8bfaa6efb39c
Autor:
Valentina Belli, Nunzia Matrone, Stefania Napolitano, Giorgia Migliardi, Francesca Cottino, Andrea Bertotti, Livio Trusolino, Erika Martinelli, Floriana Morgillo, Davide Ciardiello, Vincenzo De Falco, Emilio Francesco Giunta, Umberto Bracale, Fortunato Ciardiello, Teresa Troiani
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Abstract Background Targeting the epidermal growth factor receptor (EGFR) either alone or in combination with chemotherapy is an effective treatment for patients with RAS wild-type metastatic colorectal cancer (mCRC). However, only a small percentage
Externí odkaz:
https://doaj.org/article/2140b1307dbb4f399e9a47c0af881d05
Autor:
Emilio Francesco Giunta, Vincenzo De Falco, Stefania Napolitano, Giuseppe Argenziano, Gabriella Brancaccio, Elvira Moscarella, Davide Ciardiello, Fortunato Ciardiello, Teresa Troiani
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
BRAF-V600 mutations occur in approximately 50% of patients with metastatic melanoma. Immune-checkpoint inhibitors and targeted therapies are both active as first-line treatments in these patients regardless of their mechanisms of action and toxicitie
Externí odkaz:
https://doaj.org/article/c45fd996e87f4edaaa36576daae09cf3